{"id":872288,"date":"2025-08-07T06:04:44","date_gmt":"2025-08-07T10:04:44","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website\/"},"modified":"2025-08-07T06:04:44","modified_gmt":"2025-08-07T10:04:44","slug":"haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website\/","title":{"rendered":"Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p class=\"prntac\">\n        <b><br \/>\n          <i>Financial release accessible online<\/i><br \/>\n        <\/b>\n      <\/p>\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">BOSTON<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Aug. 7, 2025<\/span><\/span> \/PRNewswire\/ &#8212; Haemonetics Corporation (NYSE: HAE) announced that financial results for its first quarter fiscal year 2026, which ended <span class=\"xn-chron\">June 28, 2025<\/span>, are available on its Investor Relations website.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg\" title=\"\" alt=\"\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at <span class=\"xn-chron\">8:00 a.m. ET<\/span> on <span class=\"xn-chron\">August 7, 2025<\/span>. The conference call and webcast can be accessed with the following information:<\/p>\n<ul type=\"disc\">\n<li>Teleconference link:<br \/><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4483086-1&amp;h=2446236357&amp;u=https%3A%2F%2Fregister-conf.media-server.com%2Fregister%2FBIb1de2bd7b8ba4267b7bc38da4e4008c7&amp;a=https%3A%2F%2Fregister-conf.media-server.com%2Fregister%2FBIb1de2bd7b8ba4267b7bc38da4e4008c7\" target=\"_blank\" rel=\"nofollow\">https:\/\/register-conf.media-server.com\/register\/BIb1de2bd7b8ba4267b7bc38da4e4008c7<\/a><\/li>\n<li>Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.<\/li>\n<li>A live webcast of the call can be accessed on Haemonetics&#8217; investor relations website or via the following link: <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4483086-1&amp;h=93524126&amp;u=https%3A%2F%2Fedge.media-server.com%2Fmmc%2Fp%2Fwv7zkgdh&amp;a=https%3A%2F%2Fedge.media-server.com%2Fmmc%2Fp%2Fwv7zkgdh\" target=\"_blank\" rel=\"nofollow\">https:\/\/edge.media-server.com\/mmc\/p\/wv7zkgdh<\/a><\/li>\n<\/ul>\n<p>In addition, the Company has posted to its Investor Relations website the earnings release that will be referenced on its conference call and webcast, a link to which is available below.<\/p>\n<p>Direct link to 1Q FY26 Earnings Release:<br \/><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4483086-1&amp;h=2101275045&amp;u=https%3A%2F%2Fhaemonetics.gcs-web.com%2Fstatic-files%2F078498e0-b75c-4cd4-94fb-93730b3b1c70&amp;a=https%3A%2F%2Fhaemonetics.gcs-web.com%2Fstatic-files%2F078498e0-b75c-4cd4-94fb-93730b3b1c70\" target=\"_blank\" rel=\"nofollow\">https:\/\/haemonetics.gcs-web.com\/static-files\/078498e0-b75c-4cd4-94fb-93730b3b1c70<\/a><\/p>\n<p>A replay of the conference call and webcast will be available for one year beginning on <span class=\"xn-chron\">August 7, 2025<\/span>, at <span class=\"xn-chron\">11:00 a.m. ET<\/span> using the conference call webcast link provided in this press release.<\/p>\n<p>\n        <b>ABOUT HAEMONETICS<br \/><\/b>Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4483086-1&amp;h=90405323&amp;u=https%3A%2F%2Fwww.haemonetics.com%2F&amp;a=www.haemonetics.com\" target=\"_blank\" rel=\"nofollow\">www.haemonetics.com<\/a>.<\/p>\n<div>\n<table border=\"0\" cellspacing=\"0\" cellpadding=\"1\" class=\"prnbcc\">\n<tr>\n<td class=\"prngen2\" colspan=\"2\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\"><br \/>\n                  <b>Investor Contacts: <\/b><br \/>\n                <\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\" nowrap=\"nowrap\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">Olga Guyette, Vice President-Investor Relations &amp; Treasury\u00a0<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\" nowrap=\"nowrap\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">David\u00a0Trenk, Manager-Investor Relations<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">(781) 356-9763<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">(203) 733-4987<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\"><br \/>\n                  <a href=\"mailto:olga.guyette@haemonetics.com\" target=\"_blank\" class=\"prnews_a\" rel=\"nofollow\">olga.guyette@haemonetics.com<\/a><br \/>\n                <\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\"><br \/>\n                  <a href=\"mailto:david.trenk@haemonetics.com\" target=\"_blank\" class=\"prnews_a\" rel=\"nofollow\">david.trenk@haemonetics.com<\/a><br \/>\n                <\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n              \n            <\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n              \n            <\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\"><br \/>\n                  <b>Media Contact:<\/b><br \/>\n                <\/span>\n              <\/p>\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">Josh\u00a0Gitelson, Sr. Director-Global Communications <br \/><\/span>\n              <\/p>\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">(781) 356-9776<br \/><\/span>\n              <\/p>\n<p class=\"prnml4\">\n                <span class=\"prnews_span\"><br \/>\n                  <a href=\"mailto:josh.gitelson@haemonetics.com\" target=\"_blank\" class=\"prnews_a\" rel=\"nofollow\">josh.gitelson@haemonetics.com<\/a><br \/>\n                <\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n              \n            <\/td>\n<\/tr>\n<\/table><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NE45776&amp;sd=2025-08-07\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website-302523396.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website-302523396.html<\/a><\/p>\n<p>SOURCE  Haemonetics Corporation<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NE45776&amp;Transmission_Id=202508070600PR_NEWS_USPR_____NE45776&amp;DateId=20250807\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire Financial release accessible online BOSTON , Aug. 7, 2025 \/PRNewswire\/ &#8212; Haemonetics Corporation (NYSE: HAE) announced that financial results for its first quarter fiscal year 2026, which ended June 28, 2025, are available on its Investor Relations website. The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on August 7, 2025. The conference call and webcast can be accessed with the following information: Teleconference link:https:\/\/register-conf.media-server.com\/register\/BIb1de2bd7b8ba4267b7bc38da4e4008c7 Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start. A live &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-872288","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire Financial release accessible online BOSTON , Aug. 7, 2025 \/PRNewswire\/ &#8212; Haemonetics Corporation (NYSE: HAE) announced that financial results for its first quarter fiscal year 2026, which ended June 28, 2025, are available on its Investor Relations website. The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on August 7, 2025. The conference call and webcast can be accessed with the following information: Teleconference link:https:\/\/register-conf.media-server.com\/register\/BIb1de2bd7b8ba4267b7bc38da4e4008c7 Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start. A live &hellip; Continue reading &quot;Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-07T10:04:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website\",\"datePublished\":\"2025-08-07T10:04:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website\\\/\"},\"wordCount\":375,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/351568\\\/Haemonetics_Corporation_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website\\\/\",\"name\":\"Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/351568\\\/Haemonetics_Corporation_Logo.jpg\",\"datePublished\":\"2025-08-07T10:04:44+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/351568\\\/Haemonetics_Corporation_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/351568\\\/Haemonetics_Corporation_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website\/","og_locale":"en_US","og_type":"article","og_title":"Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website - Market Newsdesk","og_description":"PR Newswire Financial release accessible online BOSTON , Aug. 7, 2025 \/PRNewswire\/ &#8212; Haemonetics Corporation (NYSE: HAE) announced that financial results for its first quarter fiscal year 2026, which ended June 28, 2025, are available on its Investor Relations website. The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on August 7, 2025. The conference call and webcast can be accessed with the following information: Teleconference link:https:\/\/register-conf.media-server.com\/register\/BIb1de2bd7b8ba4267b7bc38da4e4008c7 Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start. A live &hellip; Continue reading \"Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website\/","og_site_name":"Market Newsdesk","article_published_time":"2025-08-07T10:04:44+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website","datePublished":"2025-08-07T10:04:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website\/"},"wordCount":375,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website\/","name":"Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg","datePublished":"2025-08-07T10:04:44+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/351568\/Haemonetics_Corporation_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/haemonetics-1st-quarter-fiscal-year-2026-earnings-release-available-on-investor-relations-website\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/872288","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=872288"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/872288\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=872288"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=872288"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=872288"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}